Peddock Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.17M | Buy |
9,129
+100
| +1% | +$11.7K | 0.23% | 74 |
|
|
2026
Q1 | $1.09M | Hold |
9,029
| – | – | 0.24% | 77 |
|
|
2025
Q4 | $950K | Hold |
9,029
| – | – | 0.2% | 81 |
|
|
2025
Q3 | $758K | Sell |
9,029
-510
| -5% | -$42K | 0.16% | 88 |
|
|
2025
Q2 | $755K | Sell |
9,539
-606
| -6% | -$48.2K | 0.17% | 90 |
|
|
2025
Q1 | $911K | Sell |
10,145
-1,314
| -11% | -$123K | 0.23% | 83 |
|
|
2024
Q4 | $1.14M | Sell |
11,459
-6,190
| -35% | -$638K | 0.27% | 74 |
|
|
2024
Q3 | $2M | Buy |
17,649
+287
| +2% | +$34.1K | 0.48% | 52 |
|
|
2024
Q2 | $2.15M | Buy |
17,362
+178
| +1% | +$22.9K | 0.55% | 44 |
|
|
2024
Q1 | $2.27M | Buy |
17,184
+776
| +5% | +$95.6K | 0.59% | 43 |
|
|
2023
Q4 | $1.79M | Sell |
16,408
-715
| -4% | -$74.2K | 0.55% | 46 |
|
|
2023
Q3 | $1.76M | Buy |
17,123
+329
| +2% | +$35.5K | 0.59% | 41 |
|
|
2023
Q2 | $1.94M | Buy |
16,794
+1,286
| +8% | +$146K | 0.64% | 40 |
|
|
2023
Q1 | $1.65M | Buy |
15,508
+783
| +5% | +$84.5K | 0.57% | 46 |
|
|
2022
Q4 | $1.63M | Buy |
14,725
+869
| +6% | +$88.8K | 0.63% | 44 |
|
|
2022
Q3 | $1.19M | Buy |
13,856
+1,348
| +11% | +$120K | 0.49% | 57 |
|
|
2022
Q2 | $1.14M | Buy |
12,508
+199
| +2% | +$17.6K | 0.45% | 67 |
|
|
2022
Q1 | $1.01M | Buy |
12,309
+7,823
| +174% | +$617K | 0.33% | 80 |
|
|
2021
Q4 | $344K | Buy |
4,486
+152
| +4% | +$12.1K | 0.11% | 114 |
|
|
2021
Q3 | $326K | Sell |
4,334
-3,901
| -47% | -$297K | 0.12% | 115 |
|
|
2021
Q2 | $633K | Sell |
8,235
-175
| -2% | -$13K | 0.22% | 95 |
|
|
2021
Q1 | $619K | Buy |
8,410
+900
| +12% | +$66.4K | 0.24% | 92 |
|
|
2020
Q4 | $586K | Buy |
7,510
+1,093
| +17% | +$83.6K | 0.31% | 70 |
|
|
2020
Q3 | $508K | Buy |
6,417
+816
| +15% | +$63.9K | 0.31% | 70 |
|
|
2020
Q2 | $413K | Buy |
5,601
+2,627
| +88% | +$198K | 0.26% | 75 |
|
|
2020
Q1 | $218K | Buy |
2,974
+476
| +19% | +$37.4K | 0.16% | 93 |
|
|
2019
Q4 | $217K | Hold |
2,498
| – | – | 0.11% | 102 |
|
|
2019
Q3 | $201K | Hold |
2,498
| – | – | 0.11% | 111 |
|
|
2019
Q2 | $200K | Hold |
2,498
| – | – | 0.11% | 108 |
|
|
2019
Q1 | $198K | Hold |
2,498
| – | – | 0.11% | 109 |
|
|
2018
Q4 | $182K | Hold |
2,498
| – | – | 0.11% | 110 |
|
|
2018
Q3 | $169K | Hold |
2,498
| – | – | 0.08% | 124 |
|
|
2018
Q2 | $145K | Hold |
2,498
| – | – | 0.07% | 134 |
|
|
2018
Q1 | $130K | Hold |
2,498
| – | – | 0.07% | 139 |
|
|
2017
Q4 | $134K | Hold |
2,498
| – | – | 0.07% | 138 |
|
|
2017
Q3 | $153K | Sell |
2,498
-21
| -0.8% | -$1.27K | 0.08% | 128 |
|
|
2017
Q2 | $154K | Buy |
+2,519
| New | +$153K | 0.08% | 128 |
|
|
2016
Q4 | – | Sell |
-2,744
| Closed | -$163K | – | 246 |
|
|
2016
Q3 | $163K | Buy |
+2,744
| New | +$160K | 0.1% | 106 |
|
Other funds holding MRK
ECSS
Peddock Capital Advisors's MRK Position: Q2 2026 in Review
Peddock Capital Advisors increased its Merck (MRK) stake by 1.1% in Q2 2026, buying an estimated $11.7K and bringing the position to 9,129 shares worth $1.17M. The position accounts for 0.23% of the portfolio, ranked #74.
Peddock Capital Advisors first reported a position in MRK in Q3 2016 and has held it in 38 quarters since. The position peaked at $2.27M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Peddock Capital Advisors held 9,129 shares of Merck worth $1.17M as of Q2 2026.
- Peddock Capital Advisors bought 100 Merck shares in Q2 2026, an estimated $11.7K.
- Merck made up 0.23% of Peddock Capital Advisors's portfolio in Q2 2026, its #74 holding.
- Peddock Capital Advisors first reported a position in Merck in Q3 2016 and has held it in 38 quarters since.
- Peddock Capital Advisors's Merck position peaked at $2.27M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Peddock Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.